Influenza Virus Net is the web resource for anyone interested in influenza and flu pandemics. Influenza, commonly referred to as the flu, is an infectious disease caused by RNA viruses of the family Orthomyxoviridae (the influenza viruses), that affects humans, birds and other mammals. The virus spreads easily from person to person. Influenza circulates worldwide and can affect anybody in any age group. Influenza causes annual epidemics that peak during winter in temperate regions. Influenza is a serious public health problem that causes severe illnesses and deaths for higher risk populations. The most common symptoms of the disease are chills, fever, sore throat, muscle pains, severe headache, coughing, weakness/fatigue and general discomfort. Sore throat, fever and coughs are the most frequent symptoms. In more serious cases, influenza causes pneumonia, which can be fatal, particularly for the young and the elderly. An influenza epidemic can take an economic toll through lost workforce productivity, and strain health services. Vaccination is the most effective way to prevent infection.
The objectives of Influenza Virus Net are to be the public and professional information resource for influenza and to serve as a network in the exchange of information and news related to influenza.
- The Potential Role of Patient Portals to Improve Influenza Vaccination - American Academy of Pediatrics
Thu, 01 Jul 2021 07:00 GMT
- Seqirus says it can supply 60 mln doses of influenza vaccines for U.S. flu season - Reuters
Tue, 27 Jul 2021 21:11 GMT
- Patient Portal Reminders for Pediatric Influenza Vaccinations: A Randomized Clinical Trial - American Academy of Pediatrics
Thu, 01 Jul 2021 07:00 GMT
- Into the Unknown: What Might a Combined Influenza/COVID-19 Season Look Like This Fall? - Pharmacy Times
Thu, 22 Jul 2021 16:35 GMT
- Influenza viruses could bounce back, CDC warns; urges seasonal flu shot - MassLive.com
Fri, 23 Jul 2021 13:49 GMT
- UK doctors call for flu testing as Covid threatens to coincide with influenza epidemic - CNBC
Thu, 15 Jul 2021 07:00 GMT
- Health experts are anxious to prevent a 'catastrophic' winter flu season - CNBC
Wed, 07 Jul 2021 07:00 GMT
- Influenza, Respiratory Virus Activity Fell During Height of Pandemic - AJMC.com Managed Markets Network
Fri, 23 Jul 2021 16:13 GMT
- Avian Influenza Vaccines Market: Growing prevalence of diseases to drive the market - BioSpace
Thu, 29 Jul 2021 05:52 GMT
- Equal but Not the Same—2021 Update on Influenza Vaccines - Pharmacy Times
Wed, 14 Jul 2021 07:00 GMT
- GSK begins shipping another record supply of influenza vaccine for 2021-22 season in US - PRNewswire
Fri, 23 Jul 2021 17:38 GMT
- Just One More Shot: Influenza Vaccine Hesitancy During a Pandemic - Pharmacy Times
Tue, 20 Jul 2021 07:00 GMT
- Viral Posts Misrepresent CDC Announcement on COVID-19 PCR Test - FactCheck.org
Mon, 26 Jul 2021 23:05 GMT
- Influenza-Positive Samples Undetected in England - PrecisionVaccinations
Thu, 22 Jul 2021 14:40 GMT
- Mumbai: Spike in influenza, swine flu cases; entire families getting infected - mid-day.com
Thu, 29 Jul 2021 02:34 GMT
- PRO/AH/EDR> Avian influenza, human (14): China (SC) H5N6
Sat, 24 Jul 2021 16:17:46 -0400
Avian Influenza H5N6 -- China
The Center for Health Protection of the Department of Health today [23 Jul 2021] is closely monitoring 3 new cases of human infection with avian influenza (H5N6) in the Mainland, and once again urged the public to keep [good personal, food,] and environmental hygiene.
The 1st case involved a 51-year-old woman living in Xuanhan, Sichuan Province, who had been in contact with live poultry before becoming ill. She developed symptoms on 25 Jun 2021 and was admitted to the hospital for treatment
- Vaccine effectiveness against acute respiratory illness hospitalizations for influenza-associated pneumonia during the 2015-2016 to 2017-2018 seasons, US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN) Wed, 28 Jul 2021 06:00:00 -0400
CONCLUSIONS: Influenza vaccination was modestly effective among adults in preventing hospitalizations and the need for intensive care associated with influenza pneumonia. VE was significantly higher against A (H1N1)pdm09 and was low against A (H3N2) and B.
- Altered microRNA expression in COVID-19 patients enables identification of SARS-CoV-2 infection Wed, 28 Jul 2021 06:00:00 -0400
The host response to SARS-CoV-2 infection provide insights into both viral pathogenesis and patient management. The host-encoded microRNA (miRNA) response to SARS-CoV-2 infection, however, remains poorly defined. Here we profiled circulating miRNAs from ten COVID-19 patients sampled longitudinally and ten age and gender matched healthy donors. We observed 55 miRNAs that were altered in COVID-19 patients during early-stage disease, with the inflammatory miR-31-5p the most strongly upregulated....
- Impact of pneumococcal conjugate vaccines on healthcare utilization and direct costs for otitis media in children ≤2 years of age in two Swedish regions Wed, 28 Jul 2021 06:00:00 -0400
In Sweden, the 7-valent pneumococcal conjugate vaccine (PCV7) was introduced in 2009 and replaced by the pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) or the 13-valent PCV (PCV13) from late 2009. We assessed the impact of PCVs on rates of antibiotic prescribing, tympanostomy tube placement (TTP), and healthcare resource utilization and direct costs of physician-diagnosed otitis media/acute otitis media (OM) in children ≤2 years of age living in Skåne...
- Phosphorylation of JIP4 at S730 presents anti-viral properties against influenza A virus infection Wed, 28 Jul 2021 06:00:00 -0400
Influenza A virus (IAV) is the causative agent of flu disease that results in annual epidemics and occasional pandemics. IAV alters several signaling pathways of the cellular host response in order to promote its replication. Therefore, some of these pathways can serve as targets for novel anti-viral agents. Here, we show that c-Jun NH2-terminal kinase (JNK)-interacting protein (JIP) 4 is dynamically phosphorylated in IAV infection. Lack of JIP4 resulted in higher virus titers with significant...
- The indirect antiviral potential of long non-coding RNAs encoded by IFITM pseudogenes Wed, 28 Jul 2021 06:00:00 -0400
The interferon-induced transmembrane (IFITM) family performs multiple functions in immunity, including inhibition of virus entry into cells. The IFITM repertoire varies widely between species and consists of protein-coding genes and pseudogenes. The selective forces driving pseudogenization within gene families are rarely understood. In this issue, the human pseudogene IFITM4P is characterized as a virus-induced, long non-coding RNA that contributes to restriction of Influenza A virus by...
- A case of hypercalcemia because of adrenal insufficiency induced by glucocorticoid withdrawal in a patient undergoing hemodialysis Wed, 28 Jul 2021 06:00:00 -0400
Glucocorticoids are widely used for treating underlying renal diseases and following renal transplantation and are often tapered or discontinued upon reaching end-stage renal failure. Although glucocorticoid withdrawal is the predominant cause of secondary adrenal insufficiency, no consensus has been established regarding its prevalence, clinical manifestations, or therapeutic regimen, for prevention of this pathological condition. We describe a 29-year-old woman admitted to our hospital because...
- Examining the barriers of influenza vaccine hesitancy in persons with dementia: a literature review Wed, 28 Jul 2021 06:00:00 -0400
BACKGROUND/AIMS: Despite the proven benefits of vaccine prevention and the continuous development of this important public health measure, vaccine hesitancy is among the top ten threats to global health according to the World Health Organization in 2019. Those who contract the influenza virus will typically develop a mild illness. However, for populations at a higher risk, including those diagnosed with dementia, influenza is proven to be more detrimental. Persons with dementia (PWD) face a...
- An Examination of Employee Immunization Policies Among Colorado Child Care Providers Wed, 28 Jul 2021 06:00:00 -0400
CONCLUSIONS: Our findings demonstrate the variability of employee immunization policies at child care programs across Colorado. These results may be used to inform strategies to increase employee immunization uptake and reduce the incidence of VPDs, including developing comprehensive employee immunization policies at the facility and state level. Future research is needed to understand vaccination knowledge, attitudes, and behaviors among child care employees including their perspectives on...
- IFITM proteins that restrict the early stages of respiratory virus infection do not influence late-stage replication Wed, 28 Jul 2021 06:00:00 -0400
Interferon-induced transmembrane (IFITM) proteins inhibit a broad range of enveloped viruses by blocking entry into host cells. We used an inducible overexpression system to investigate if IFITM1, IFITM2 and IFITM3 could modulate early and/or late stages of influenza A virus (IAV) or parainfluenza virus (PIV)-3 infection in human A549 airway epithelial cells. IAV and PIV-3 represent respiratory viruses which utilise distinct cellular entry pathways. We verify entry by endocytosis for IAV,...
- Hemagglutinins of avian influenza viruses are proteolytically activated by TMPRSS2 in human and murine airway cells Wed, 28 Jul 2021 06:00:00 -0400
Cleavage of the influenza A virus (IAV) hemagglutinin (HA) by host proteases is indispensable for virus replication. Most IAVs possess a monobasic HA cleavage site cleaved by trypsin-like proteases. Previously, the transmembrane protease TMPRSS2 was shown to be essential for proteolytic activation of IAV HA subtypes H1, H2, H7 and H10 in mice. In contrast, additional proteases are involved in activation of certain H3 IAVs, indicating that HAs with monobasic cleavage site can differ in their...